亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Stable incidence and survival of arteriovenous fistulas over 39 years: A long-term national cohort study

医学 期限(时间) 入射(几何) 外科 队列 内科学 人口学 动静脉瘘 数学 几何学 量子力学 物理 社会学
作者
Kristine Lindhard,Ditte Hansen,Brian Pedersen,Marianne Rix,Henrik Post Hansen,Boye L. Jensen,James Heaf
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:24 (4): 620-629 被引量:2
标识
DOI:10.1177/11297298211046102
摘要

INTRODUCTION: The age and number of comorbidities in the hemodialysis population has increased over time. This may influence the construction and survival of the arteriovenous fistula (AVF). The present study explored the incidence and survival of AVFs over a period of 39 years. METHODS: A retrospective cohort study was conducted based on Danish registries. Incident hemodialysis patients between 1977 and 2015 were included. The incidence of AVF and factors associated with the construction of an AVF were described. Risk factors for AVF survival and repair were explored by Kaplan Meier and Cox proportional hazard analysis. RESULTS: The total number of arteriovenous accesses (AVF and arteriovenous grafts) were 10,187 and there were 4201 central venous catheters (CVC). No significant difference in the proportion of AVFs during the 39 years was seen. Age and renal diagnosis did not influence the proportion of AVFs. Patients with CVCs were found to have a significantly higher prevalence of comorbidities ( p < 0.01). AVF survival remained stable during the 39 years. The first constructed AVF had the best survival, 35% still functioning after 15 years. Factors such as brachiocephalic AVF, female sex, and diabetic nephropathy increased the risk of AVF failure (Odds Ratio (OR): 2.46, 95% Confidence Interval (CI) (2.29-2.65), 1.17 (1.10-1.25), and 1.21 (1.12-1.3)), respectively. CONCLUSION: Despite an older dialysis population, the proportion and survival of the AVF in the Danish dialysis population has not changed, probably because of increased awareness of AVF as the first choice of vascular access and improved surveillance, surgery, and repair.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
stagger发布了新的文献求助10
14秒前
stagger发布了新的文献求助10
1分钟前
CC完成签到,获得积分10
1分钟前
研友_VZG7GZ应助科研通管家采纳,获得10
1分钟前
隐形曼青应助科研通管家采纳,获得10
1分钟前
刘子发布了新的文献求助10
1分钟前
清风明月完成签到 ,获得积分10
1分钟前
haprier完成签到 ,获得积分10
2分钟前
2分钟前
zyz发布了新的文献求助10
2分钟前
科研通AI6.1应助zyz采纳,获得10
2分钟前
刘子完成签到,获得积分10
2分钟前
刘鑫慧完成签到 ,获得积分10
2分钟前
3分钟前
d22110652发布了新的文献求助10
3分钟前
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
赘婿应助科研通管家采纳,获得10
3分钟前
3分钟前
OK应助科研通管家采纳,获得20
3分钟前
3分钟前
3分钟前
d22110652完成签到,获得积分10
3分钟前
3分钟前
Jasper应助Amadeus采纳,获得10
4分钟前
无语的傥发布了新的文献求助10
4分钟前
无语的傥完成签到,获得积分10
5分钟前
彭于晏应助科研通管家采纳,获得10
5分钟前
Carl完成签到 ,获得积分10
6分钟前
cqbrain123完成签到,获得积分10
6分钟前
脑洞疼应助科研通管家采纳,获得10
7分钟前
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
李健应助科研通管家采纳,获得10
7分钟前
cqhecq完成签到,获得积分10
7分钟前
8分钟前
极乐鸟发布了新的文献求助10
8分钟前
114koi完成签到,获得积分20
8分钟前
顾矜应助极乐鸟采纳,获得10
8分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Adhesion Science: Principles & Practice 800
The Graphene Handbook (2019 Edition) 700
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6529518
求助须知:如何正确求助?哪些是违规求助? 8322398
关于积分的说明 17816953
捐赠科研通 5631001
什么是DOI,文献DOI怎么找? 2931610
邀请新用户注册赠送积分活动 1908097
关于科研通互助平台的介绍 1767426